Organon & Co. Common Stock (NY:OGN)

13.72 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Organon & Co. Common Stock

< Previous 1 2

...

14 15 16 17 18 19 20 21 Next >

Samsung Bioepis & Organon Announce FDA Acceptance of Supplemental Biologics License Application (sBLA) for Interchangeability Designation for HADLIMA™ (adalimumab-bwwd), a Biosimilar to Humira®

November 07, 2023

From Samsung Bioepis

Via GlobeNewswire

Organon: Dividend Insights ↗

November 07, 2023

Via Benzinga

Analyst Ratings for Organon ↗

November 03, 2023

Via Benzinga

Organon Reports Results for the Third Quarter Ended September 30, 2023

November 02, 2023

From Organon & Co.

Via Business Wire

Organon and Sempre Health Announce Collaboration on New Service to Help Eligible Patients Save Money and Stay on Their Medication as Prescribed

November 01, 2023

From Organon & Co.

Via Business Wire

A Look Into Healthcare Sector Value Stocks ↗

October 30, 2023

Via Benzinga

Organon To Report Third Quarter Results and Host Conference Call on November 2, 2023

October 19, 2023

From Organon & Co.

Via Business Wire

Lululemon Athletica Races to New High with S&P 500 Entry

October 17, 2023

Lululemon's stock soared 10.31%, its best level since late 2021, upon joining the S&P 500, replacing Activision Blizzard. The change is effective October 18.

Via MarketBeat

Topics Stocks

Lululemon Athletica To Join S&P 500 Index; LULU Stock Flashes Buy Signal ↗

October 13, 2023

The yoga retailer will join the index before Wednesday's open.

Via Investor's Business Daily

Topics Stocks

10 Health Care Stocks Whale Activity In Today's Session ↗

October 02, 2023

Via Benzinga

Organon Recognized on Fortune’s 2023 Change the World List for Leadership in Expanding Access to Contraceptive Choice

September 27, 2023

From Organon & Co.

Via Business Wire

5 Value Stocks To Watch In The Healthcare Sector ↗

September 25, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2023 ↗

September 21, 2023

Via Benzinga

First Real-World Observational Study of the JADA® System, a Medical Device to Control Postpartum Hemorrhage (PPH), Published in ACOG’s Obstetrics & Gynecology

September 14, 2023

From Organon & Co.

Via Business Wire

3 Pharmaceutical Stocks That Are Too Cheap to Ignore ↗

September 09, 2023

Viatris, GSK, and Organon are all trading at less than 7 times earnings.

Via The Motley Fool

Stock Analysis: Organon & Co. ↗

September 07, 2023

Organon & Co. sells its products to drug wholesalers, retailers, hospitals, pharmacies, clinics, government agencies, and other institutions worldwide.

Via Talk Markets

Organon Bolsters Research & Development Expertise with Two Leadership Appointments

September 05, 2023

From Organon & Co.

Via Business Wire

3 Undervalued Healthcare Stocks In 2023 ↗

August 31, 2023

These 3 undervalued healthcare stocks in 2023 are attractive today for their attractive valuations and total return potential.

Via Talk Markets

A Look Into Healthcare Sector Value Stocks ↗

August 14, 2023

Via Benzinga

Organon Reports Results for the Second Quarter Ended June 30, 2023

August 08, 2023

From Organon & Co.

Via Business Wire

5 Value Stocks In The Healthcare Sector ↗

August 07, 2023

Via Benzinga

Samsung Bioepis & Organon Announce Topline Results from Interchangeability Study of SB5 Humira Biosimilar

August 01, 2023

From Samsung Bioepis

Via GlobeNewswire

Overview Of Value Stocks In The Healthcare Sector ↗

July 31, 2023

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

July 24, 2023

Via Benzinga

Need an Extra $4,000 in Dividends Each Year? Invest $68,000 in These 3 Stocks. ↗

July 21, 2023

These stocks can significantly bolster your income.

Via The Motley Fool

Datadog, IQVIA, Organon And An Oilfield Services Giant Rolling Out An AI Platform: CNBC's 'Final Trades' ↗

July 17, 2023

On CNBC’s "Halftime Report Final Trades," Jason Snipe of Odyssey Capital Advisors said he likes IQVIA Holdings Inc. (NYSE: IQV)

Via Benzinga

Organon To Report Second Quarter Results and Host Conference Call on August 8, 2023

July 17, 2023

From Organon & Co.

Via Business Wire

REPEAT/Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA™ (adalimumab-bwwd) in Multiple Presentations Consistent with Originator

July 05, 2023

From Organon

Via Business Wire

3 S&P 500 Stocks to Own for the Next 50 Years ↗

July 04, 2023

These three S&P 500 companies all buy and hold stocks for the next 50 years or more because they operate in attractive industries.

Via InvestorPlace

Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA™ (adalimumab-bwwd) in Multiple Presentations Consistent with Originator

July 01, 2023

From Organon & Co.

Via Business Wire

< Previous 1 2

...

14 15 16 17 18 19 20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.